1. Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics

   • Moustapha Hassan
   • Gunnar Öberg
   • Mariette Lindgren

   Original Articles Pages: 181 - 186

2. Extended-release formulation of morphine for subcutaneous administration

   • Taehee Kim
   • Joon Kim
   • Sinil Kim

   Original Articles Pages: 187 - 190

3. The role of reduced nicotinamide adenine dinucleotide phosphate in glucose- and temperature-dependent doxorubicin cytotoxicity

   • Jian-Ping Gao
   • Stanley Friedman
   • Karl W. Lanks

   Original Articles Pages: 191 - 196

4. Preclinical pharmacology of the antitumor agentO-6-methylguanine in CDF1 mice

   • Vassilios I. Avramis
   • Kenneth K. Chan
   • Zhan-liu Chen

   Original Articles Pages: 197 - 202

5. Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study

   • Everett E. Vokes
   • Daniel J. Haraf
   • Philip C. Hoffman

   Original Articles Pages: 203 - 209

6. Differential cytotoxicity of buthionine sulfoximine to “normal” and transformed human lung fibroblast cells

   • X. Steven Wan
   • Daret K. St. Clair

   Original Articles Pages: 210 - 214

7. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells

   • Jeong-Hyung Lee
   • Mikihiko Naito
   • Takashi Tsuruo

   Original Articles Pages: 215 - 220

8. Phase I study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in metastatic adenocarcinoma patients

   • Georg A. Bjarnason
   • Ian G. Kerr
   • Marcia Sone

   Original Articles Pages: 221 - 228

9. β-Cyclodextrin tetradecasulfate/tetrahydrocortisol±minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic lewis lung carcinoma

   • Beverly A. Teicher
   • Enrique Alvarez Sotomayor
   • Ying-Nan Chen

   Original Articles Pages: 229 - 238

10. Covalent modification of DNA by daunorubicin

    • Madhu Purewal
    • Joachim G. Liehr

    Original Articles Pages: 239 - 244

11. Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis

    • Edith A. Perez
    • Frank M. Hack
    • Ting-Chao Chou

    Original Articles Pages: 245 - 250

12. Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration

    • Steven A. Curley
    • Diana L. Stone
    • Robert A. Newman

    Original Articles Pages: 251 - 257

13. Pharmacokinetics of an extended-release human interferon alpha-2b formulation

    • Andrea Bonetti
    • Sinil Kim

    Original Articles Pages: 258 - 261

14. Proteinuria due to suboptimal hydration with high-dose methotrexate therapy

    • G. T. Kovács
    • Ch. Paál
    • J. D. Borsi

    Short Communication Pages: 262 - 263

15. Meeting announcement

    Announcement Pages: 264 - 264